Chitosan-derivative compounds and methods of controlling microbial populations

作者: William P. Wiesmann , Shenda Baker , Shannon Ryan

DOI:

关键词:

摘要: The present invention is directed to chitosan-derivative compounds and structures, methods of making for controlling, inhibiting enhancing microbial populations in a variety environments. also the control, inhibition enhancement animals, particularly humans. include bacteria, viruses other pathogens where control are necessity. chitosan-arginine compounds, related chitosan-L/D unnatural amino acid chitosan-acid amine natural derivative co-derivatives salts chitosan chitosan-guanidine compounds.

参考文章(133)
Ana Isabel Vila Pena, Silvia Suarez Luque, Ma Jose Alonso Fernandez, Stable nanocapsule systems for the administration of active molecules ,(2007)
Yasuhiro Kanatani, Tetsuro Kiyozumi, Yoshiaki Okada, Hirofumi Yura, Yoshinori Misawa, Masayuki Ishihara, Daizoh Saitoh, Medical composition for promotion of skin regeneration ,(2006)
Giovanni M. Pauletti, Kishorkumar J. Desai, Donald C. Harrison, Susan L. Roweton, Lyndia M. Sanders, Therapeutic compositions for drug delivery to and through covering epithelia ,(2003)
Kil-Hyun Park, Soon-Hong Lee, Jae-Hyeok Choi, Hyang-Ja You, Yong-Ju Kim, Yong-ho Kim, Seon-Jeong Kim, Separation and purification of low molecular weight chitosan using multi-step membrane separation process ,(1997)